Citation Tools

PDF

Extended report
Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)

Download to a citation manager

Cite this article as:
Burmester GR, Rubbert-Roth A, Cantagrel A, et al
Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)